IP Library Granted Patent US 8,123,698
Granted Patent B2
US 8,123,698 · App. 11/237,110 · Granted Feb 28, 2012

System and method for minimally invasive disease therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,123,698
App. No.
11/237,110
Granted
Feb 28, 2012
Kind
B2
Abstract

A system for treating a lesion site of a patient is disclosed. The system includes a cannula having a lumen, a conduit in communication with said lumen, an introducer stylet removably disposed within said cannula, a resecting device selectively insertable within said cannula, and an adjuvant treatment device selectively insertable within said cannula.

Claims (40)

1. A system for treating a lesion site of a patient, comprising:

a cannula having a lumen;

a conduit in communication with said lumen;

an introducer stylet removably disposed within said cannula;

a resecting device selectively insertable within said cannula; and

an adjuvant treatment device selectively insertable within said cannula, wherein the adjuvant treatment device includes a shield covering a portion of said adjuvant treatment device for protecting a non-targeted tissue region, and a first exterior region and a second exterior region diametrically opposite said first exterior region, said first exterior region and said second exterior region arranged at a common axial location along said adjuvant treatment device, said shield extending over said first exterior region and not over said second exterior region, and wherein at least a portion of the shield is selectively insertable within said cannula;

wherein the resecting device is a separate component from the adjuvant treatment device.

2. The system of claim 1 , further comprising:

a limiting member configured to limit penetration of said cannula within said patient.

3. The system of claim 2 , wherein said limiting member is arranged outside of said cannula and includes an exterior surface for selectively contacting one of said patient's skin and a reference structure for controlling said position of said cannula within said patient.

4. The system of claim 3 , wherein said limiting member engages an exterior surface of said cannula.

5. The system of claim 1 , further comprising:

a vacuum passage positioned between said lumen and said adjuvant treatment device, said vacuum passage at least partially defined by an inner surface of said lumen and an outer surface of said adjuvant treatment device.

6. The system of claim 1 , further including a vacuum device for creating a vacuum, wherein said vacuum applied to said conduit causes a tissue cavity to collapse upon said adjuvant treatment device.

7. The system of claim 1 , wherein said adjuvant treatment device operates using at least one of cryo-ablation, radiofrequency-ablation, heating, brachytherapy, and photodynamic therapy.

8. The system of claim 1 , further comprising:

a target confirmation device selectively insertable within the cannula.

9. The system of claim 1 , wherein said lumen includes an open proximal end through which said introducer stylet, said resecting device and said adjuvant treatment device are inserted into and removed from said cannula, and an opposite distal end, said system further comprising a valve fluidly connected to said lumen, said valve selectively moveable between an open position for establishing a fluid path between said distal and proximal ends of said lumen, and a closed position for substantially fluidly blocking said fluid path between said distal and proximal ends of said lumen.

10. An adjuvant therapy system for a lesion site, comprising:

a cannula having a lumen;

a port in communication with said lumen;

a limiting member moveably connected to said cannula and configured to position said cannula within said patient;

a reference structure configured to selectively engage said limiting member, said reference structure including at least one aperture for slidably receiving said cannula;

an introducer stylet selectively and removably disposed within said cannula;

a debulking device selectively insertable within said cannula, said debulking device configured for removing tissue from said lesion site;

an adjuvant treatment device selectively insertable within said cannula for treating the lesion site, wherein the debulking device is a separate component from the adjuvant treatment device; and

a vacuum source operably connected to said port, wherein said vacuum source causes a tissue cavity to collapse upon said adjuvant treatment device.

11. The adjuvant therapy system of claim 10 , further comprising:

a target confirmation device selectively insertable within said cannula.

12. The adjuvant therapy system of claim 10 , wherein said adjuvant treatment device utilizes at least one of cryo-ablation, radiofrequency-ablation, heating, and photodynamic therapy.

13. The adjuvant therapy system of claim 10 , wherein a photosensitizing agent is delivered to said lesion site.

14. The adjuvant therapy system of claim 13 , wherein said adjuvant treatment device illuminates said lesion site.

15. The adjuvant therapy system of claim 10 , wherein said limiting member is arranged outside of said cannula and includes an exterior surface for selectively contacting one of said patient's skin and a reference structure to control said position of said cannula within said patient.

16. The adjuvant therapy system of claim 15 , wherein said limiting member engages an exterior surface of said cannula.

17. The adjuvant therapy system of claim 10 , wherein said lumen includes an open proximal end through which said introducer stylet, said resecting device and said adjuvant treatment device are inserted into and removed from said cannula, and an opposite distal end, said adjuvant therapy system further comprising a valve fluidly connected to said lumen, said valve selectively moveable between an open position for establishing a fluid path between said distal and proximal ends of said lumen, and a closed position for substantially fluidly blocking said fluid path between said distal and proximal ends of said lumen.

18. The system of claim 17 , wherein said valve is arranged along said fluid path between said port and said proximal end of said lumen.

19. A surgical treatment apparatus comprising:

a cryo-ablation probe having a distal end, and a first exterior region and a second exterior region diametrically opposite said first exterior region, said first exterior region and said second exterior region arranged at a common axial location along said adjuvant treatment device, wherein said distal end is insertable at least partially through a cannula and ablates a first tissue when located adjacent said first exterior region; and

a shield extending over said first exterior region for protecting a second tissue and not extending over said second exterior region, said shield insertable at least partially through the cannula.

20. The apparatus of claim 19 , wherein said shield is partially constructed from at least one of plastic, rubber, or PTFE.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →